Nobuyuki Katakami

16.9k citations
216 papers · 6.4k indexed · 1 hit paper · h-index 47
Topics
Lung Cancer Treatments and Mutations (134 papers)Lung Cancer Research Studies (85 papers)Lung Cancer Diagnosis and Treatment (57 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer
Partner nations
JapanUnited StatesItaly

In The Last Decade

Nobuyuki Katakami

206 papers receiving 6.2k citations

Hit Papers

CNS Efficacy of Osimertinib in Patients With T790M-Positi...20182026202020232018100200300

Peers

Nobuyuki Katakami
Comparison fields: 5 of 116
  • Pulmonary and Respiratory Medicine 4.5k
  • Oncology 3.8k
  • Molecular Biology 1.3k
  • Surgery 788
  • Cancer Research 607
Replace Tae‐You Kim with:
Tae‐You Kim South Korea
Tsutomu Fujii Japan
Masayuki Ohue Japan
Mitsuro Kanda Japan
Kyung-Hun Lee South Korea
Tomoyuki Yokose Japan
Laëtitia Dahan France
Margarita Majem Spain
Tatsuro Okamoto Japan
Xiaoyun Liao United States
Nobuyuki Katakami relative to Tae‐You Kim South Korea Tae‐You Kim's profile →
Citations per field
00.5×1.5×1.8×
Tae‐You Kim · 1×
Citations per year

Countries citing papers authored by Nobuyuki Katakami

Since Specialization
Citations

This map shows the geographic impact of Nobuyuki Katakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuyuki Katakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuyuki Katakami more than expected).

Fields of papers citing papers by Nobuyuki Katakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuyuki Katakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuyuki Katakami. The network helps show where Nobuyuki Katakami may publish in the future.

Co-authorship network of co-authors of Nobuyuki Katakami

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuyuki Katakami. A scholar is included among the top collaborators of Nobuyuki Katakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuyuki Katakami. Nobuyuki Katakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 15
2 0
3 2
4 4
5 9
6 5
7 28
8
CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non–Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)breakdown →
349
9 13
10 12
11 2
12 47
13 1
14 1
15 89
16 8
17 25
18 1
19
[Lung cancer with bone metastasis].
11
20 34

About Nobuyuki Katakami

Nobuyuki Katakami is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 216 papers that have together received 6.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (134 papers), Lung Cancer Research Studies (85 papers) and Lung Cancer Diagnosis and Treatment (57 papers). The work is most often cited by research in Oncology (3.8k citations), Pulmonary and Respiratory Medicine (4.5k citations) and Cancer Research (607 citations). Nobuyuki Katakami has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Akito Hata, Shunichi Negoro, Keisuke Tomii, Koji Takeda, Masahiro Fukuoka, Kazuhiko Nakagawa, Toyoaki Hida, Shiro Fujita, Nobuyuki Yamamoto and Reiko Kaji. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026